Fluence Energy receives a Buy rating with a 12-month price target of $9, contingent on resolving production bottlenecks at its Houston plant. The company faces supply constraints rather than demand issues, with a backlog of $6.4 billion and Q3 orders totaling $1.44 billion. Success depends on ramping production to 10 units per day by 2027 at Houston. Key risks include ongoing delays, potential equity dilution, credit facility changes, and customer concentration after acquiring AES.
Fluence Energy's stock price on Pluang is currently USD 5.80, down 4.76% as of Oct 30, 2026, 15:41 WIB, reflecting some investor caution. The company holds a market cap of $886.90 million and an enterprise value of $939.73 million on the platform. This trading activity coincides with ongoing concerns about production bottlenecks at its Houston plant, as detailed in the news.
Investors in Fluence Energy, Qfin Holdings, Endava, and Anavex Life Sciences have until November 30, 2026, to file motions to be lead plaintiffs in securities fraud class actions. These lawsuits allege the companies made misleading statements about t...
Fluence Energy faces a class action lawsuit accusing it of securities fraud after its stock fell 35% due to alleged misrepresentations about its manufacturing operations and ability to meet revenue and EBITDA targets. The lawsuit claims Fluence false...
